Clinical variability in approaches to polycystic ovary syndrome.

MedStar author(s):
Citation: Journal of Pediatric & Adolescent Gynecology. 25(4):259-61, 2012 Aug.PMID: 22840936Institution: MedStar Washington Hospital CenterDepartment: Obstetrics and Gynecology/Pediatric and AdolescentForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Metabolic Syndrome X/di [Diagnosis] | *Physician's Practice Patterns | *Polycystic Ovary Syndrome/di [Diagnosis] | *Polycystic Ovary Syndrome/th [Therapy] | Adolescent | Contraceptives, Oral/tu [Therapeutic Use] | Cross-Sectional Studies | Data Collection | Exercise | Female | Food Habits | Hormones/bl [Blood] | Humans | Hypoglycemic Agents/tu [Therapeutic Use] | Metabolic Syndrome X/co [Complications] | Metformin/tu [Therapeutic Use] | Mineralocorticoid Receptor Antagonists/tu [Therapeutic Use] | Polycystic Ovary Syndrome/co [Complications] | Referral and Consultation | Sex Hormone-Binding Globulin | Spironolactone/tu [Therapeutic Use]Local holdings: Available online through MWHC library: 2002 - presentISSN:
  • 1083-3188
Name of journal: Journal of pediatric and adolescent gynecologyAbstract: CONCLUSION: Considerable practice heterogeneity was present with regards to diagnostic testing for suspected PCOS. Recommendations for first-line therapy were more consistent. Future studies should clarify the clinical utility of specific diagnostic tests for adolescents, such that selection of diagnostic testing is evidence based. Copyright 2012 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.DESIGN: Cross-sectional, anonymous, internet surveyPARTICIPANTS: NASPAG membership (N = 326; Respondents = 127 (39%))RESULTS: Percentage of respondents who incorporated specific tests at initial diagnosis was highly variable ranging from 87% (thyroid stimulating hormone) to 17% (sex hormone binding globulin). Oral contraceptives and diet modification/exercise were the most common therapies recommended by 98% and 90% of respondents respectively.STUDY OBJECTIVE: The objective of this study was to evaluate methods of initial diagnosis and management of polycystic ovary syndrome (PCOS) among members of the North American Society for Pediatric and Adolescent Gynecology (NASPAG) to assess the degree of practice heterogeneity among specialist providers of adolescent care.All authors: Appelbaum H, Bonny AE, Connor EL, Cromer B, DiVasta A, Gomez-Lobo V, Harel Z, Huppert J, NASPAG Research Committee, Sucato GDigital Object Identifier: Date added to catalog: 2013-09-17
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article Available 22840936

Available online through MWHC library: 2002 - present

CONCLUSION: Considerable practice heterogeneity was present with regards to diagnostic testing for suspected PCOS. Recommendations for first-line therapy were more consistent. Future studies should clarify the clinical utility of specific diagnostic tests for adolescents, such that selection of diagnostic testing is evidence based. Copyright 2012 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.

DESIGN: Cross-sectional, anonymous, internet survey

PARTICIPANTS: NASPAG membership (N = 326; Respondents = 127 (39%))

RESULTS: Percentage of respondents who incorporated specific tests at initial diagnosis was highly variable ranging from 87% (thyroid stimulating hormone) to 17% (sex hormone binding globulin). Oral contraceptives and diet modification/exercise were the most common therapies recommended by 98% and 90% of respondents respectively.

STUDY OBJECTIVE: The objective of this study was to evaluate methods of initial diagnosis and management of polycystic ovary syndrome (PCOS) among members of the North American Society for Pediatric and Adolescent Gynecology (NASPAG) to assess the degree of practice heterogeneity among specialist providers of adolescent care.

English

Powered by Koha